Résultats de recherche - Portail des modèles médicaux de données (portail MDM)

Filtrer les résultats de recherche
Sélectionner modèles de données

Modèles de données sélectionnés

Vous devez être connecté pour sélectionner plusieurs modèles de données, les télécharger ou les analyser.

192 Résultats de recherche.

Eligibility NCT00700102 Colorectal Cancer - Eligibility

- 16/04/2014 - 1 Formulaire, 2 Groupes Item, 11 Eléments de données, 2 Langues

Groupes Item: Inclusion Criteria, Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00700102

Eligibility NCT00528567 Breast Cancer - Eligibility

- 10/12/2013 - 1 Formulaire, 2 Groupes Item, 8 Eléments de données, 2 Langues

Groupes Item: Inclusion Criteria, Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00528567

quality management ADT-final data cancer - quality management

- 27/09/2021 - 1 Formulaire, 5 Groupes Item, 32 Eléments de données, 2 Langues

Groupes Item: Patientendaten, Patientenadresse, Nachsorge, Gesamtbeurteilung des Tumorstatus, Patient verstorben

base-dataset from ADT - final data, ODM derived from http://www.tumorzentren.de/tl_files/dokumente/adt_basis.pdf

dataset Patient and Diagnosis Data cancer - dataset

- 20/09/2021 - 1 Formulaire, 12 Groupes Item, 153 Eléments de données, 2 Langues

Groupes Item: Patient data, -, Diagnosis, Tumor site, Histopathology , Diagnostic Accuracy, -, distant metastasis , tumor marker, planned therapeutic procedure, planned therapeutic procedure, -

clinical cancer registry used in Münster

quality management ADT-systemic therapy cancer - quality management

- 20/09/2021 - 1 Formulaire, 7 Groupes Item, 69 Eléments de données, 2 Langues

Groupes Item: Patientendaten, Patientenadresse, Therapieform, Therapie, Beendigung der Systemischen Therapie, Erfolg, Nebenwirkungen

base-dataset from ADT - systemic therapy, ODM derived from http://www.tumorzentren.de/tl_files/dokumente/adt_basis.pdf

dataset minimal dataset DPKK prostate cancer - dataset

- 07/08/2013 - 1 Formulaire, 9 Groupes Item, 49 Eléments de données, 2 Langues

Groupes Item: Datenelemente I, Topographie, Datenelemente II, PSA, Datenelemente III, Art der durchgeführten Operation, Datenelemente IV, Histomorphologie des Prostatektomiepräparates, Datenelemente V

with friendly permission, http://www.dpkk.de, Minimaldatensatz des DPKK

Eligibility DRKS00009656 NCT00069745 Prostate Cancer - Eligibility

- 20/09/2021 - 1 Formulaire, 3 Groupes Item, 34 Eléments de données, 2 Langues

Groupes Item: Inclusion criteria, Exclusion criteria, Medical Concepts

Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen Inclusion Criteria: - Stage D2 metastatic prostate cancer - Progression after one prior chemotherapy - ECOG Performance status equal / less than 2 - Life expectancy > 3 months - Surgical or medical castration - Adequate bone marrow, hepatic and renal functions - Informed consent Exclusion Criteria: - More than one prior chemotherapy - Prior platinum containing compounds - Prior malignancy - Prior significant RT/radionuclide therapy - Major GI surgery or GI disease affecting absorption - Disease with contraindication to steroids - Brain metastases

Eligibility DRKS00004052 NCT00661609 Bladder Cancer - Eligibility Advanced Bladder Cancer NCT00661609

- 17/09/2021 - 1 Formulaire, 2 Groupes Item, 8 Eléments de données, 1 Langue

Groupes Item: Inclusion criteria, Exclusion criteria

Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) See http://clinicaltrials.gov/ct2/show/record/NCT00661609

Bladder Cancer NCT00014534 Follow-Up - CALGB: 90104 New Primary Cancer Form - 2169482v3.0 - CALGB: 90104 New Primary Cancer Form

- 09/01/2015 - 1 Formulaire, 1 Groupe Item, 16 Eléments de données, 1 Langue

Groupe Item: CCRR MODULE

CALGB: 90104 New Primary Cancer Form Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B57B8-FFB5-70FA-E034-0003BA12F5E7

Cancer Treatments Protocol PhenX Toolkit

- 26/04/2016 - 1 Formulaire, 1 Groupe Item, 18 Eléments de données, 1 Langue

Groupe Item: PhenX - cancer treatment protocol

These questions start by asking if the respondent has had cancer. For respondents who have had cancer, detailed follow-up questions ask about the type of cancer treatment, including surgery, chemotherapy, radiation, and hormone therapy. ODM derived from: https://cde.nlm.nih.gov Primary source: https://www.phenxtoolkit.org/ Recent publication: Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., and Hamilton, C.M. (2015) Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86:1.21.1-1.21.17. doi: 10.1002/0471142905.hg0121s86 Permission to publish granted by Carol M. Hamilton.

Eligibility DRKS00003984 NCT00887198 Prostate Cancer - Eligibility

- 17/04/2014 - 1 Formulaire, 2 Groupes Item, 10 Eléments de données, 2 Langues

Groupes Item: Inclusion Criteria, Exclusion Criteria

ODM derived from http://clinicaltrials.gov/show/NCT00887198

Eligibility DRKS00003880 NCT00273338 Prostate Cancer - Eligibility

- 13/04/2014 - 1 Formulaire, 3 Groupes Item, 35 Eléments de données, 2 Langues

Groupes Item: Inclusion Criteria, Exclusion Criteria, Medical Concepts

ODM derived from http://clinicaltrials.gov/show/NCT00273338

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.